issuer: november Aktiengesellschaft Hansaring 97 D-50670 Köln phone: +49(0)221-82005 20-10 FAX: +49(0)221-82005 20-15 mail: info@november.de WWW: http://www.november.de sector: Biotechnology ISIN: DE000A0Z24E9 indexes: CDAX, Prime All Share, Technology All Share stockmarkets: free trade: Hannover, Berlin, München, Düsseldorf, Stuttgart, regulated dealing/prime standard: Frankfurt language: English ...
issuer: november Aktiengesellschaft Hansaring 97 D-50670 Köln phone: +49(0)221-82005 20-10 FAX: +49(0)221-82005 20-15 mail: info@november.de WWW: http://www.november.de sector: Biotechnology ISIN: DE000A0Z24E9 indexes: CDAX, Prime All Share, Technology All Share stockmarkets: regulated dealing/prime standard: Frankfurt, free trade: Berlin, Stuttgart, Düsseldorf, Hannover, München language: English ...
company: november Aktiengesellschaft Hansaring 97 D-50670 Köln phone: +49(0)221-82005 20-10 FAX: +49(0)221-82005 20-15 mail: info@november.de WWW: http://www.november.de sector: Biotechnology ISIN: DE000A0Z24E9 indexes: CDAX, Prime All Share, Technology All Share stockmarkets: regulated dealing/prime standard: ...
company: november Aktiengesellschaft Hansaring 97 D-50670 Köln phone: +49(0)221-82005 20-10 FAX: +49(0)221-82005 20-15 mail: info@november.de WWW: http://www.november.de sector: Biotechnology ISIN: DE000A0Z24E9 indexes: CDAX, Prime All Share, Technology All Share stockmarkets: regulated dealing/prime standard: ...
company: november Aktiengesellschaft Hansaring 97 D-50670 Köln phone: +49(0)221-82005 20-10 FAX: +49(0)221-82005 20-15 mail: info@november.de WWW: http://www.november.de sector: Biotechnology ISIN: DE000A0Z24E9 indexes: CDAX, Prime All Share, Technology All Share stockmarkets: regulated dealing/prime standard: Frankfurt, free trade: Berlin, Stuttgart, Düsseldorf, ...
november AG plans a significant capital reduction to cover losses Contact: Dr. Dirk Zurek Vorstand Tel.: +49 (0) 221 82200 520 10 E-Mail: ir@november.de Branche: Biotechnology ISIN: DE000A0Z24E9 WKN: A0Z24E Index: CDAX, Prime All Share, Technology All Share Börsen: Frankfurt / regulated dealing/prime standard ...
Overall result of the group nearly break-even Significant cost reduction Liabilities reduced further Surpluses in HGB separate financial statements Increase in adjusted sales revenues Significant increase in gross margin Significantly improved margin Contact: Dr. Dirk Zurek Vorstand/CEO Tel.: ...
New Products/Research & Development Köln (euro adhoc) - Effective immediately, PROGEN Biotechnik GmbH, a subsidiary of november AG, exclusively distributes the PATHFAST® analyzing system of Mitsubishi Chemical Europe GmbH in Germany. The PATHFAST® analyzing system enables effective parallel processing of up to ...
Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. Mergers - Acquisitions - Takeovers Cologne, Heidelberg, Regensburg (euro adhoc) - Effective January 1, 2011 PROGEN Biotechnik GmbH, Heidelberg, and Multimetrix GmbH, Regensburg, both ...
ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. 04.01.2011 Today, november AG (ISIN: DE000A0Z24E9) succeeded in negotiating an extensive waiver of debts with ...
PROGEN Biotechnik GmbH reports significant sales increase Significant increase in operating profit Significantly improved margins Consolidated results nearly break-even Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this ...
New: KRAS/BRAF Test for Luminex-User New: AmplideX FMR1 PCR-Assay Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. New Products/Research & Development/Distribution Subtitle: New: KRAS/BRAF Test for Luminex-User New: AmplideX FMR1 ...
Collaboration in the field of Luminex xMAP® technology Segmentation of activities Exploitation of synergies Expansion of product range Development of new markets Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. Joint ...
ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. 29.09.2010 Today, the management and the supervisory boards of november AG have decided not to pursue the ...
ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. 09.09.2010 Cologne, September 9, 2010 Today, november AG and alpha Vermögensverwaltungs- und Beteiligungsmanagement GmbH & Co. KG signed a letter of intent for the ...
Additional CE certified tests from PROGEN / Multimetrix for a two-step diagnostic of Lyme Borreliosis are approved for laboratory diagnosis Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. New Products Subtitle: Additional CE ...
Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. 6-month report Köln (euro adhoc) - Half-Year Results 2010 Confirm: november AG On Target Publication of consolidated operating results as of June 30, 2010 PROGEN Biotechnik GmbH achieves positive operating results Stable revenues of TEUR 1.806 Consulting ...